Phylo, a Stanford spin-out, has just launched as an applied lab focused on agentic AI for biomedical research. Alongside the launch, the team announced Biomni …
Read More
Inductive Bio placed first in the OpenADMET-ExpansionRx blind challenge with its Beacon models, a large-scale industry competition for ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) …
Read More
The modern obesity drug race has been defined by one word: incretins. Blockbuster GLP-1 receptor agonists from companies like Novo Nordisk and Eli Lilly have …
Read More
Anthropic has formalized partnerships with the Howard Hughes Medical Institute (HHMI) and the Allen Institute to integrate its Claude model into core scientific workflows, targeting …
Read More
Despite rising trial costs and increasingly complex development timelines, one trend is clear: digital health technologies are rapidly moving from pilot programs to core components …
Read More
Eli Lilly has entered a collaboration with Seamless Therapeutics worth up to $1.12 billion to co-develop gene editing therapies targeting genetic forms of hearing loss. …
Read More
